Schedule 13D ownership disclosure
LARIMAR THERAPEUTICS INC
Security class unavailable · CUSIP: 517125100
Event date: 2024-03-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.6400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-24-000378
- Form type
- SC 13D
- Filer
- Flynn James E
- CIK
- CIK 1352546
- Filed
- Mar 15, 2024
- Reporting period
- Mar 14, 2024
- Description
- Schedule 13D beneficial ownership